# CureForge AI – Autonomous Research Institute Architecture

## 1. Technical Architecture for 100K–1M AI Agents
To scale CureForge AI to hundreds of thousands or millions of agents, the system should adopt a distributed hierarchical architecture.

**Layer 1 – Global Director Agent**
Coordinates system-wide priorities, resource allocation, and discovery strategy.

**Layer 2 – Domain Supervisor Agents**
Each supervisor manages a scientific domain such as neurodegeneration, metabolic aging, immune aging, and cardiovascular aging.

**Layer 3 – Research Worker Agents**
These agents perform tasks such as literature mining, dataset analysis, and hypothesis testing.

**Infrastructure Stack:**
* **Containerization:** Docker
* **Orchestration:** Kubernetes
* **Task Queues:** Kafka / RabbitMQ
* **Vector Databases:** Milvus / Weaviate
* **Storage:** Distributed object storage (S3 compatible)
* **Monitoring:** Prometheus + Grafana

The system dynamically spawns agents when new hypotheses or datasets appear and retires agents when research threads become unproductive.

## 2. Longevity Discovery Pipeline
CureForge agents should operate a structured discovery pipeline.

* **Step 1 – Data ingestion:** Agents gather biomedical literature, clinical trials, omics datasets, and biomarker studies.
* **Step 2 – Knowledge graph reasoning:** The system links genes, pathways, drugs, and diseases.
* **Step 3 – Hypothesis generation:** Agents generate candidate interventions such as drug combinations, biomarker targets, or pathway modulation strategies.
* **Step 4 – Simulation testing:** Digital twin simulations evaluate lifespan impact, toxicity risk, and biomarker effects.
* **Step 5 – Ranking interventions:** Hypotheses are ranked by predicted healthspan gain, mechanistic plausibility, and safety profile.
* **Step 6 – Experimental proposal:** Agents design preclinical or clinical experiments to validate discoveries.

## 3. Longevity Knowledge Graph Schema
**Nodes in the graph include:**
* Genes
* Proteins
* Biological pathways
* Drugs
* Biomarkers
* Diseases
* Clinical trials

**Edges represent relationships such as:**
* Activation
* Inhibition
* Association
* Clinical evidence
* Causal relationships

**Example reasoning chain:**
`Drug → Pathway → Hallmark of Aging → Disease risk → Longevity impact`

## 4. Autonomous Research Cycle Protocol
Each agent follows a structured research cycle:
1. **Observe** – gather new data or literature.
2. **Analyze** – extract structured relationships.
3. **Hypothesize** – propose candidate interventions.
4. **Simulate** – test hypotheses in digital twin models.
5. **Evaluate** – measure predicted outcomes.
6. **Archive** – store results in knowledge graph and memory system.

Agents collaborate by sharing findings through the central knowledge graph.

## 5. Scientific Validation Framework
To convert discoveries into real scientific impact, CureForge must implement validation pipelines.

**Validation levels:**
* **Level 1** – Statistical validation using large biomedical datasets.
* **Level 2** – Mechanistic validation through pathway modeling.
* **Level 3** – Simulation validation in digital twin populations.
* **Level 4** – Experimental validation via laboratory studies.
* **Level 5** – Clinical validation through human trials.

Automated outputs can include research reports, clinical trial proposals, and draft scientific manuscripts.
